North American Neuroendocrine Tumor Society

01/31/2026

Stay connected with NANETS! Our newsletter brings you the latest in neuroendocrine tumor (NET) research, clinical updates, career opportunities, and member stories — everything you need to stay informed. Subscribe today: https://loom.ly/mErILxM

01/27/2026

The NET Regional Conference in Nashville, TN is happening on March 28! 🗓️ Connect with experts across specialties for the latest updates in NET pathology, diagnosis & treatment. Gain practical insights to enhance patient care & outcomes. Register now: https://loom.ly/vhfScTA

01/26/2026

This NETCast episode features Dr. Uday Grewal hosting a discussion with Drs. Aman Chauhan, Renuka Iyer, and Shagufta Shaheen on the complexities of hybrid neuroendocrine cancers. The panel explores transformation cases, mixed histology, and emerging DLL3-targeted therapies with lung cancer and CAR-T expertise.

🎙️ Listen now: https://loom.ly/tIJkFIA

NETCast · Episode

01/22/2026

Raise your voice for better cancer care! Join the ACT Network to send ready-to-go messages to lawmakers, track important legislation, and stay informed on the issues that matter most.
Start here: https://loom.ly/Ag8C-OI

Write a letter to your lawmaker today!

01/20/2026

The Neuroendocrine Cancer Foundation (NCF), recently released a special podcast episode recapping highlights from our 2025 Multidisciplinary NET Medical Symposium. Designed with patients and caregivers in mind, the episode translates complex scientific updates into clear, accessible insights, reinforcing the importance of shared understanding between the clinical and patient communities. Listen here: https://loom.ly/WRKHnyE

01/16/2026

This NETCast episode from the 2025 NANETS Symposium features Dr. Theodora Dimitra hosting a discussion with Drs. Alexandria Phan, Paul Herr, Dawn Quelle, and Andrew Bellizzi on a range of hot topics. The panel discusses challenging NET clinical scenarios including biomarkers, GLP-1 medications, and surgical decision-making. 🎙️ Listen now: https://loom.ly/SEjU2Os

01/12/2026

January isn’t just the start of a new calendar year; it’s also one of the most active periods for research planning across academic medicine. Historically, Q1 is a peak time for finalizing NIH grant submissions, launching new study concepts, and opening clinical trial protocols, as investigators align fresh ideas with new funding cycles and institutional priorities.

For the NET community, this means that many of the studies, therapies, and biomarkers highlighted at future NANETS Symposia are being conceptualized right now, in early brainstorming meetings, protocol drafts, and cross-disciplinary collaborations. In that sense, the new year isn’t only about reflection; it’s about laying the groundwork for the next wave of discovery that will shape NET care in the years ahead. https://loom.ly/z0ff2dQ

01/08/2026

As we look ahead to 2026, the NET community reflects on a year of meaningful progress. At the 2025 NANETS Annual Multidisciplinary NET Medical Symposium, Dr. Simron Singh’s NET Year in Review highlighted advances across therapies, diagnostics, biomarkers, and clinical decision-making.

Pivotal trials expanded treatment options across NET subtypes, while targeted therapies and radioligand treatments showed broader and more durable impact. Biomarkers and imaging reinforced the move toward more precise, individualized care, and new data challenged long-held assumptions in surgery and liver-directed therapy. With updated guidelines, improving survival, and emerging topics like AI and GLP-1 receptor agonists, the field enters 2026 better equipped to translate discovery into patient impact.

01/06/2026

As we welcome 2026, the NANETS Board of Directors thanks our members, volunteers, staff, partners, and sponsors for making this community so strong. Your dedication drove meaningful progress in education, multidisciplinary care, advocacy, and research in 2025. We look ahead to 2026 with optimism and momentum and wish you a healthy, fulfilling New Year as we continue advancing care for patients with neuroendocrine tumors.

12/30/2025

We’re collecting responses for the “Why NENs?” Early-Career Survey, and we’re only about halfway to the number needed for meaningful, actionable data. If you’re early in your NET career, please take a few minutes to share what brought you into the field, what keeps you engaged, and the challenges you’re facing.

Your feedback directly shapes future programming, resources, and support for early-career members. Please complete the survey, and help us reach full participation by sharing it with colleagues and trainees.

Your voice matters, and it only takes a few minutes to make an impact: https://loom.ly/SwXuAt8

12/22/2025

As planning begins for the 2026 Multidisciplinary NET Medical Symposium in Las Vegas, we continue to welcome topic and session ideas from the NANETS community. If you have emerging research, clinical challenges, case-based concepts, or multidisciplinary themes you believe should be highlighted next year, we encourage you to submit your suggestions. Your input helps ensure the program reflects the evolving needs of the field and continues to deliver timely, relevant, and impactful education for the NET community.

Submission Deadline: Friday, January 9, 2026

Add your ideas, share your expertise, and help us build a dynamic and forward-thinking program for 2026.

12/19/2025

This episode of NETCast features a panel on NET patient advocacy. They explore why advocacy is critical for this rare cancer, discussing challenges patients face at diagnosis, the importance of education and resources, research funding obstacles, and political advocacy efforts. The panel emphasizes that patients should be active participants in advocacy—whether through contacting reprsentatives, supporting research organizations, or engaging in educational initiatives—to make this "invisible" disease visible and drive meaningful change in treatment and outcomes.

🎙️ Listen now: https://loom.ly/vUzPWdU